Establishment Labs (NASDAQ:ESTA – Get Free Report) and QT Imaging (NASDAQ:QTI – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.
Insider and Institutional Ownership
72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Establishment Labs and QT Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Establishment Labs | -15.82% | -196.69% | -10.73% |
| QT Imaging | -77.25% | -1,202.69% | -46.76% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Establishment Labs | 1 | 0 | 8 | 0 | 2.78 |
| QT Imaging | 1 | 1 | 1 | 0 | 2.00 |
Establishment Labs currently has a consensus price target of $100.25, indicating a potential upside of 44.12%. Given Establishment Labs’ stronger consensus rating and higher probable upside, equities analysts plainly believe Establishment Labs is more favorable than QT Imaging.
Earnings & Valuation
This table compares Establishment Labs and QT Imaging”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Establishment Labs | $245.82 million | 8.43 | -$51.06 million | ($1.31) | -53.10 |
| QT Imaging | $18.92 million | 1.91 | -$21.08 million | ($1.57) | -1.67 |
QT Imaging has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Establishment Labs beats QT Imaging on 10 of the 13 factors compared between the two stocks.
About Establishment Labs
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.
